OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Jamieson on Symptom Management in Myelofibrosis

July 21st 2021

Catriona Jamieson, MD, PhD, discusses symptom management in patients with myelofibrosis.

Dr. Kiladjian on Improving Transfusion-Independence Rates With Momelotinib in Myelofibrosis

July 21st 2021

Jean-Jacques Kiladjian, MD, PhD, discusses the potential utility of momelotinib in improving transfusion-independence rates in myelofibrosis.

Dr. Venook on the Unmet Need Addressed by The GALAXY Trial Examining ctDNA in CRC

July 20th 2021

Alan P. Venook, MD, discusses the unmet need addressed by the GALAXY trial, part of the CIRCULATE-Japan project, which is examining circulating tumor DNA in patients with resectable colorectal cancer.

Dr. Xavier on Recent Updates in DLBCL

July 20th 2021

Marin F. Xavier, MD, discusses recent updates in diffuse large B-cell lymphoma based on data from the 2021 ASCO Annual Meeting.

Dr. Jones on Targeting HER2 Alterations in CRC

July 20th 2021

Jeremy C. Jones, MD, discusses targeting HER2 alterations in colorectal cancer.

Dr. Costa Discusses Ongoing Research Efforts in TNBC

July 20th 2021

Ricardo Costa, MD, MSc, discusses ongoing research efforts in triple-negative breast cancer.

Dr. Motzer on the Importance of Assessing Health-Related QOL in RCC

July 20th 2021

Robert J. Motzer, MD, discusses the importance of assessing health-related quality of life in renal cell carcinoma.

Dr. Ahmed on Optimizing Treatment With Axi-Cel in LBCL

July 20th 2021

Sairah Ahmed, MD, discusses optimizing treatment with axicabtagene ciloleucel in large B-cell lymphoma.

Dr. Ghia on Key Findings From the CAPTIVATE Trial in CLL

July 19th 2021

Paolo Ghia, MD, PhD, discusses key findings from the phase 2 CAPTIVATE trial in chronic lymphocytic leukemia.

Dr. Verstovsek on Efficacy of Pelabresib Plus Ruxolitinib in Myelofibrosis

July 19th 2021

Srdan Verstovsek, MD, PhD, discusses the efficacy of the combination of pelabresib plus ruxolitinib in the treatment of patients with myelofibrosis.

Dr. Flowers on Long-Term Efficacy With Tafasitamab Plus Lenalidomide in DLBCL

July 19th 2021

Christopher Flowers, MD, discusses the long-term efficacy with tafasitamab-cxix in combination with lenalidomide in diffuse large B-cell lymphoma.

Dr. Ma on First-Line Treatment Considerations in Metastatic Pancreatic Cancer

July 19th 2021

Wen Wee Ma, MBBS, discusses first-line treatment considerations in metastatic pancreatic cancer.

Dr. Lyou on Emerging Biomarkers in Prostate Cancer

July 19th 2021

Yung Lyou, MD, PhD, discusses emerging biomarkers in prostate cancer.

Dr. O’Donnell on the Promise of Novel Targets in Multiple Myeloma

July 19th 2021

Betsy O'Donnell, MD, discusses the promise of novel targets in multiple myeloma.

Dr. Thomas on the Safety Profile of Lifileucel Plus Pembrolizumab in Advanced Melanoma

July 19th 2021

Sajeve Samuel Thomas, MD, discusses the safety profile of lifileucel plus pembrolizumab in advanced melanoma.

Dr. Tolaney on Tailoring HER2-Directed Therapy in Breast Cancer

July 19th 2021

Sara M. Tolaney, MD, MPH, discusses tailoring HER2-directed therapies in the treatment of patients with breast cancer.

Dr. Chase on Utilizing Genetic Testing to Guide Treatment Decisions in Ovarian Cancer

July 19th 2021

Dana Chase, MD, FACOG, discusses the importance of utilizing genetic testing to guide treatment decisions for patients with ovarian cancer.

Dr. Shirasu on the Design for the GALAXY Trial Examining ctDNA in CRC

July 19th 2021

Hiromichi Shirasu, MD, discusses the design of the GALAXY trial, part of the CIRCULATE-Japan project, which is examining circulating tumor DNA in patients with resectable colorectal cancer.

Dr. Pollyea on Indications for Anti-CD33 Therapy in AML

July 19th 2021

Daniel Pollyea, MD, MS, discusses indications for anti-CD33 therapy in the treatment of patients with acute myeloid leukemia.

Dr. Atallah on the Clinical Implications of the QUAZAR AML-001 Trial in AML

July 16th 2021

Ehab L. Atallah, MD, discusses the clinical implications of the phase 3 QUAZAR AML-001 trial in acute myeloid leukemia.